Navigation Links
Champions Biotechnology, Inc. Establishes UK Subsidiary and Retains General Manager to Expand Its Personalized Oncology Business
Date:4/8/2009

es. As drugs progress through preclinical development, the Company intends to sell, partner or license them to pharmaceutical and/or biotechnology companies, as appropriate. The Company also offers its predictive preclinical platform and tumor specific data to physicians for personalized patient care and to Companies for evaluation of oncology drugs in models that integrate prognostic testing with biomarker discovery.

Champions Biotechnology is dedicated to enhancing preclinical development tools, accelerating development and valuation of oncology drugs, and advancing personalized treatment with a goal to improve the lives of cancer patients globally.

This press release contains "forward-looking statements" (within the meaning of the Private Securities Litigation Act of 1995) that inherently involve risk and uncertainties. Champions Biotechnology generally uses words such as "believe," "may," "could," "will," "intend," "expect," "anticipate," "plan," and similar expressions to identify forward-looking statements. One should not place undue reliance on these forward-looking statements. The Company's actual results could differ materially from those anticipated in the forward-looking statements for many unforeseen factors. See Champions Biotechnology's Form 10-KSB for the fiscal year ended April 30, 2008 for a discussion of such risks, uncertainties and other factors. Although the Company believes the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and Champions Biotechnology's future results, levels of activity, performance or achievements may not meet these expectations. The Company does not intend to update any of the forward-looking statements after the date of this press release to conform these statements to actual results or to changes in Champions Biotechnology's expectations, except as required by law.


'/>"/>
SOURCE Champions Biotechnology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Dr. David Sidransky Appointed Chairman of Champions Biotechnology, Inc.
2. Ferring Pharmaceuticals Announces EUFLEXXA(TM) as Title Sponsor of the National Senior Games Hockey Championships and the GeezerJock of the Year Award
3. Champions Biotechnology, Inc. Appoints New Board Members and Forms Management Team
4. Champions Biotechnology, Inc. Completes $2,500,000 Private Financing at $1.75 per Share
5. Champions Biotechnology and ImClone Systems Establish Agreement for Preclinical Evaluation of Oncology Drugs
6. Champions Biotechnology Reports Fiscal 2008 Full-Year Financial Results
7. Champions Biotechnology Reports Fiscal 2009 Third Quarter Financial Results
8. Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc.
9. Kun Run Biotechnology, Inc. Year-End Revenues Increase 56% to $11.6 million
10. Cardinal Health Establishes $1 Million Grant Fund for Initiatives That Improve Quality, Safety of Patient Care
11. N.C. Takes Biofuels Leadership, Establishes New Endeavor With $5 Million State Appropriation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...0 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX...edical-device research and,development outsourcing...tates,announced that it had been selected to the ...e fifth consecutive year. The list recognizes the ..., media, and telecommunications,industries based o...
(Date:11/27/2009)...27 Cromoz Inc., located in Researc...n nanotube-based cancer drug delivery system in Hy..., which have functional groups on the walls that a...oped in partnership with the Indian Institute of K...s as a drug delivery vehicle with the ability to t...
(Date:11/25/2009)...Newswire/ -- Biotech firm Replikins Ltd., which ha...918 pandemic through the prediction, outbreak, and...ed its latest biochemical analysis of the virus. T..."Swine Flu") virus has dropped from its peak of 3....n the spring of 2009 to resting non-epidemic level...
(Date:11/25/2009)...PRNewswire/ -- Reportlinker.com announces that a n...logue: ,, Brazil Bioethanol Market Analysis an...r.com/p0165503/Brazil-Bioethanol-Market-Analysis-a... Market Analysis and Forecasts to 2013 ,, Summ...nd forecasts of the global bioethanol market and t...
Breaking Biology Technology:WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year 2North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10
...June 26 Barr Pharmaceuticals,Inc. (NYSE: BRL ) t...re has,ruled in favor of its subsidiary, Barr Labo...ted by Boehringer Ingelheim Pharmaceuticals, Inc. ...R) Tablets (pramipexole,dihydrochloride) 0.125mg, ...ict Court Judge Joseph J. Farnan, Jr. found that,t...
... to Measure ROI, Balance Business Benefits with ...FALLS CHURCH, Va., and ATLANTA, June 26 Companies...constrained by the,inability to justify cost of im... Study," a new survey jointly conducted by CSC (NY...NH ), IBM and Supply Chain Management Review,magaz...
...ses New Flexibility for Pandemic Planning -, NUTL...duction of a flexible purchase program that will a...wn stockpile of Tamiflu(R) for use in a,pandemic s... adaptability,to deal with unknown factors inheren...nesses pay a nominal annual fee to "reserve",their...
Other Biology Technology:Barr Announces Favorable Ruling in Mirapex(R) Patent Challenge 2Barr Announces Favorable Ruling in Mirapex(R) Patent Challenge 3Barr Announces Favorable Ruling in Mirapex(R) Patent Challenge 4Study Reveals Greatest Barrier to Green Supply Chain Initiatives 2Study Reveals Greatest Barrier to Green Supply Chain Initiatives 3Roche Introduces Program to Facilitate Corporate Pandemic Stockpiling of Tamiflu(R) 2Roche Introduces Program to Facilitate Corporate Pandemic Stockpiling of Tamiflu(R) 3Roche Introduces Program to Facilitate Corporate Pandemic Stockpiling of Tamiflu(R) 4Roche Introduces Program to Facilitate Corporate Pandemic Stockpiling of Tamiflu(R) 5
(Date:11/25/2009)... heart pumps some 250 million liters of blood thro...fibers of the heart have to be extremely durable. ...r, vice chair of the Department of Medicine III at...r. H. A. Katus), has discovered a protein that is ...ular unit, the sarcomere. In cooperation with othe...
(Date:11/25/2009)...just as vital to your health as what you eat, foun... Studies. Their experiments in mice revealed that ...in the liverthe body,s metabolic clearinghouseis m...y,s circadian clock as conventional wisdom had it....a large number of genes completely independent of ...
(Date:11/24/2009)... today named 12 new grant recipients for 2009. The...ve work across a broad spectrum of lupus research....and potential to drive scientific discovery to ult...se of systemic lupus. , The 2009 grants go to bo...e nation and include interdisciplinary and highly ...
Breaking Biology News(10 mins):New genetic cause of cardiac failure discovered 2Feeding the clock 2Feeding the clock 3Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Jean Pol Tassin wins the 2009 ECNP Neuropsychopharmacological Award 10055 1Successful Dieters Show Unique Brain Patterns 58125 1Successful Dieters Show Unique Brain Patterns 58125 2Sambazon Introduces New Refreshing Antioxidant Elixir 58121 1Sambazon Introduces New Refreshing Antioxidant Elixir 58121 2
... Humans have regularly been introducing exotic spe... for their nutritional necessities or meet less in... or hunting. However, the particular environments ...ast introduction attempts, such as that of wild ra...hern hemisphere water courses, led to an awareness...
... CSIRO is collaborating in a NASA-funded project, ... new methods of measuring forest carbon stores on ...ground carbon store and are therefore critical in ...g the amount of carbon stored in forests over a la...ng the CSIRO-designed ECHIDNA instrument, together...
... The beaches of French Guiana constitute a major r... turtle, although a protected species, is threaten...identally caught in fishing nets, sees its egg-lay...y for their meat and their eggs. Female turtles re... lay their eggs. What happens in the interval rema...
Other Biology News:Conservation of freshwater fish biodiversity: a challenge for the countries of the South 2Conservation of freshwater fish biodiversity: a challenge for the countries of the South 3Isotope analysis reveals foraging area dichotomy for Atlantic leatherback turtles 2
...a simple and efficient means for isolation of apop...gnetic beads (MagBeads). Annexin V is a Ca2+-depen...ty for phosphatidylseri The Apoptotic Cell Isolat...isolation of apoptotic cells or removal of dead ce...
CORNING CELLSTACK CAP, 33MM, PHENOL from Sigma-Aldrich
...ocycler combines top performance with exquisite de... and unparalleled temperature uniformity. The inst...amming in a spreadsheet or alternatively in a grap...n the push of a button and swings in a defined end...
Techne hybridization oven accessories from Sigma-Aldrich
Biology Products: